Claudia V.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
- Phase 2 Randomized, Blinded, Placebo-Controlled Study of INBRX-109 in Adults with Unresectable or Metastatic Conventional Chondrosarcoma
Data & Insights
Has run more than one trial at 135 of 275 partner sites.
Specializations
Soft Tissue Sarcomas
The investigator specializes in treating various types of soft tissue sarcomas, with particular emphasis on liposarcoma, synovial sarcoma, and leiomyosarcoma. Their research explores novel therapeutic combinations including radiation therapy and innovative drug treatments.
- Advanced and metastatic sarcomas
- Combination therapy approaches
- Novel therapeutic agents
Bone Sarcomas
Focuses on treating aggressive bone cancers, particularly Ewing sarcoma and osteosarcoma. The investigator works with both primary and recurrent cases, implementing innovative treatment strategies including targeted therapies and immunotherapy approaches.
- Refractory disease management
- Multi-drug combinations
- Advanced stage treatments
Gastrointestinal Oncology
Specializes in the treatment of gastrointestinal stromal tumors, with expertise in adjuvant therapy approaches. The investigator's work includes investigating extended treatment protocols and recurrence prevention strategies.
- Targeted molecular therapies
- Risk-adapted treatment
- Long-term disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.